Google researchers announced that their new artificial intelligence algorithm can predict heart disease by scanning the patient's eye.
With a bit of help from CT scans at a UC San Diego Health hospital and 3-D printing, an injured sea turtle is thriving again.
The test doesn't detect concussions and the approval won't immediately change how patients with suspected concussions are treated. But it allows Banyan Biomarkers to commercialize its test, giving the company an early lead in the race to find a way to diagnose concussions.
Hospital bed supplier Hill-Rom Holdings said today that CEO John J. Greisch will retire. The Chicago-based company has begun a search for a new CEO and expects to complete it in the April-to-June quarter.
Hill-Rom CEO John Greisch is betting there's more money to be made in blood pressure monitors and retina-scanning devices than adjustable hospital mattresses.
The CMS will ask the White House to allow it to evaluate whether states are overpaying for medical equipment in comparison to Medicare rates. Medical equipment providers say the crackdown comes as they are already struggling financially.
Like the rest of the healthcare industry, the medical-device industry has been consolidating at a rapid clip as companies look to increase their leverage with providers.
IlliniCare, a private insurer that's part of Illinois Gov. Bruce Rauner's Medicaid managed-care overhaul, is cutting reimbursement rates to medical suppliers by up to 50%.
Norman Regional Health System is bundling its equipment purchasing to reduce costs and improve care.
More and more medical procedures are moving to the strip mall, thanks to high-deductible insurance plans that are turning patients into penny-pinchers. Hospital systems like Edward-Elmhurst Health are reacting, hedging their bets on what have been lucrative captive practices.
The controversial competitive bidding program saved the CMS $26 billion over 10 years. Yet, similar savings could be obtained through a market-based approach, a new study found.
The $2 billion acquisition of NxStage will allow Fresenius to capture market share in the home dialysis segment and capitalize on payment models that favor coordinated care, analysts said.